145 related articles for article (PubMed ID: 12376361)
1. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease.
Schmidt R; Meier U; Markart P; Grimminger F; Velcovsky HG; Morr H; Seeger W; Günther A
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1079-85. PubMed ID: 12376361
[TBL] [Abstract][Full Text] [Related]
2. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
[TBL] [Abstract][Full Text] [Related]
3. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
[TBL] [Abstract][Full Text] [Related]
5. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
6. [Surfactant lipids of bovine lungs].
Ledwozyw A; Tusińska E; Tusiński M
Pol Arch Weter; 1991; 31(3-4):93-104. PubMed ID: 1842618
[TBL] [Abstract][Full Text] [Related]
7. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases.
Honda Y; Tsunematsu K; Suzuki A; Akino T
Lung; 1988; 166(5):293-301. PubMed ID: 3146676
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls.
IJsselstijn H; Zimmermann LJ; Bunt JE; de Jongste JC; Tibboel D
Crit Care Med; 1998 Mar; 26(3):573-80. PubMed ID: 9504589
[TBL] [Abstract][Full Text] [Related]
9. Loss of lymphocyte modulatory control by surfactant lipid extracts from acute hypersensitivity pneumonitis: comparison with sarcoidosis and idiopathic pulmonary fibrosis.
Lesur O; Mancini NM; Janot C; Chabot F; Boitout A; Polu JM; Gérard H
Eur Respir J; 1994 Nov; 7(11):1944-9. PubMed ID: 7875263
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
11. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
12. The influence of temperature, phylogeny, and lung structure on the lipid composition of reptilian pulmonary surfactant.
Daniels CB; Orgeig S; Smits AW; Miller JD
Exp Lung Res; 1996; 22(3):267-81. PubMed ID: 8792121
[TBL] [Abstract][Full Text] [Related]
13. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
14. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
[TBL] [Abstract][Full Text] [Related]
15. Chronic inhalation exposure and phospholipids in lung surfactant and tissue.
Nishimura I; Negishi T
Toxicol Lett; 1995 Jan; 75(1-3):185-91. PubMed ID: 7863525
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary surfactant in cystic fibrosis.
Griese M; Birrer P; Demirsoy A
Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary surfactant composition following MACC chemotherapy for lung carcinoma.
Rossi GA; Balbi B; Benatti U; Morelli A; Sacco O; Vassallo F; Ravazzoni C
Eur J Respir Dis; 1987 Nov; 71(5):400-9. PubMed ID: 2832202
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids.
Robinson PC; Watters LC; King TE; Mason RJ
Am Rev Respir Dis; 1988 Mar; 137(3):585-91. PubMed ID: 3345040
[TBL] [Abstract][Full Text] [Related]
19. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant activity is impaired in lung transplant recipients.
Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
